Trevi Therapeutics (TRVI) Cash from Financing Activities (2018 - 2026)
Trevi Therapeutics' quarterly Cash from Financing Activities came in at $222000.0 in Q1 2026, down 97.45% year-on-year from $8.7 million in Q1 2025, and down 21.83% quarter-over-quarter from $284000.0 in Q4 2025.
Trevi Therapeutics has reported Cash from Financing Activities for 9 years, with the latest figure at $222000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 97.45% year-over-year to $222000.0; the trailing twelve-month figure through Mar 2026 stood at $112.5 million (up 60.26% YoY), and the FY2025 full-year result was $121.0 million, up 96.82% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $222000.0, down from $284000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $110.4 million in Q2 2025, with the low at -$7.7 million in Q2 2023.
- Average Cash from Financing Activities over 5 years is $16.8 million, with a median of $1.5 million recorded in 2023.
- Year-over-year, Cash from Financing Activities tumbled 172.48% in 2023 and jumped 95409.26% in 2024.
- Tracing TRVI's Cash from Financing Activities over 5 years: stood at $652000.0 in 2022, then plunged by 108.28% to -$54000.0 in 2023, then jumped by 95409.26% to $51.5 million in 2024, then sank by 99.45% to $284000.0 in 2025, then slipped by 21.83% to $222000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $222000.0 (Q1 2026), $284000.0 (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | 222,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 222,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Dec 31, 2025 | 284,000.00 |
| Dec 31, 2025 | 284,000.00 |
| Sep 30, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 110.40 Mn |
| Jun 30, 2025 | 110.40 Mn |
| Mar 31, 2025 | 8.71 Mn |
| Mar 31, 2025 | 8.71 Mn |
| Dec 31, 2024 | 51.47 Mn |
| Dec 31, 2024 | 51.47 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Jun 30, 2024 | 5.07 Mn |
| Jun 30, 2024 | 5.07 Mn |
| Mar 31, 2024 | -28,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | -54,000.00 |
| Dec 31, 2023 | -54,000.00 |
| Sep 30, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | -7.66 Mn |
| Jun 30, 2023 | -7.66 Mn |
| Mar 31, 2023 | -1.70 Mn |
| Mar 31, 2023 | -1.70 Mn |
| Dec 31, 2022 | 652,000.00 |
| Dec 31, 2022 | 652,000.00 |
| Sep 30, 2022 | 55.30 Mn |
| Sep 30, 2022 | 55.30 Mn |
| Jun 30, 2022 | 55.98 Mn |
| Jun 30, 2022 | 55.98 Mn |
| Mar 31, 2022 | -625,000.00 |
| Mar 31, 2022 | -625,000.00 |
| Dec 31, 2021 | 13.74 Mn |
| Dec 31, 2021 | 13.74 Mn |
| Sep 30, 2021 | 134,000.00 |
| Sep 30, 2021 | 134,000.00 |
| Jun 30, 2021 | 2.75 Mn |
| Jun 30, 2021 | 2.75 Mn |
| Mar 31, 2021 | 4.15 Mn |
| Mar 31, 2021 | 4.15 Mn |
| Dec 31, 2020 | 637,000.00 |
| Dec 31, 2020 | 637,000.00 |
| Sep 30, 2020 | 16.10 Mn |
| Sep 30, 2020 | 16.10 Mn |
| Sep 30, 2019 | -138,000.00 |
| Sep 30, 2019 | -138,000.00 |
| Jun 30, 2019 | 63.50 Mn |
| Jun 30, 2019 | 63.50 Mn |
| Mar 31, 2019 | 9.85 Mn |
| Mar 31, 2019 | 9.85 Mn |
| Dec 31, 2018 | -1.51 Mn |
| Dec 31, 2018 | -1.51 Mn |
| Sep 30, 2018 | 10.47 Mn |
| Sep 30, 2018 | 10.47 Mn |
| Jun 30, 2018 | -3.28 Mn |
| Jun 30, 2018 | -3.28 Mn |
| Mar 31, 2018 | -2.05 Mn |
| Mar 31, 2018 | -2.05 Mn |